Specifying a GLP 28-Day Repeat-Dose Toxicology, Toxicokinetic, and Immunogenicity Study of a Once-Weekly Basal Insulin Analogue in Rat and Dog: A Request-for-Proposal Framework Supporting FDA IND Submission

Insulin analogues designed for once-weekly administration change the safety-study problem in three ways: pharmacologic hypoglycemia limits the dose, species clear the molecule far faster than people do, and an antibody response can both alter exposure and cross-react with endogenous insulin. This article builds a request for proposal (RFP) for a GLP 28-day repeat-dose subcutaneous toxicology, toxicokinetic, and immunogenicity study in rat and dog with a 14-day recovery phase, for a hypothetical acylated basal insulin analogue that binds albumin reversibly. It sets out the class-level rationale, the applicable ICH, FDA, and EMA guidance, a modular scope, group and animal tables (150 animals), a glucose monitoring and hypoglycemia rescue plan, an eight-month schedule, a line-item budget with a total estimate of USD 751,351, and scoring criteria weighted toward GLP quality, insulin or peptide experience, and antibody capability. Recommendations close with advice on confidentiality and intellectual property in vendor relationships.Keywords: request for proposal; basal insulin analogue; repeat-dose toxicity; toxicokinetics; immunogenicity; hypoglycemia; ICH S6(R1); GLP

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24425278
Primary Topic
Animal testing and alternatives
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Specifying a GLP 28-Day Repeat-Dose Toxicology, Toxicokinetic, and Immunogenicity Study of a Once-Weekly Basal Insulin Analogue in Rat and Dog: A Request-for-Proposal Framework Supporting FDA IND Submission

Peivand Pirouzi, Happy Makvana, Drashti Patel, Sahil Patel
Zenodo (CERN European Organization for Nuclear Research)
Animal testing and alternatives
article

Specifying a GLP 28-Day Repeat-Dose Toxicology, Toxicokinetic, and Immunogenicity Study of a Once-Weekly Basal Insulin Analogue in Rat and Dog: A Request-for-Proposal Framework Supporting FDA IND Submission

Peivand Pirouzi, Happy Makvana, Drashti Patel, Sahil Patel
article en

Abstract

Insulin analogues designed for once-weekly administration change the safety-study problem in three ways: pharmacologic hypoglycemia limits the dose, species clear the molecule far faster than people do, and an antibody response can both alter exposure and cross-react with endogenous insulin. This article builds a request for proposal (RFP) for a GLP 28-day repeat-dose subcutaneous toxicology, toxicokinetic, and immunogenicity study in rat and dog with a 14-day recovery phase, for a hypothetical acylated basal insulin analogue that binds albumin reversibly. It sets out the class-level rationale, the applicable ICH, FDA, and EMA guidance, a modular scope, group and animal tables (150 animals), a glucose monitoring and hypoglycemia rescue plan, an eight-month schedule, a line-item budget with a total estimate of USD 751,351, and scoring criteria weighted toward GLP quality, insulin or peptide experience, and antibody capability. Recommendations close with advice on confidentiality and intellectual property in vendor relationships.Keywords: request for proposal; basal insulin analogue; repeat-dose toxicity; toxicokinetics; immunogenicity; hypoglycemia; ICH S6(R1); GLP

Zenodo (CERN European Organization for Nuclear Research)
Northeastern University (US)
Animal testing and alternatives
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Specifying a GLP 28-Day Repeat-Dose Toxicology, Toxicokinetic, and Immunogenicity Study of a Once-Weekly Basal Insulin Analogue in Rat and Dog: A Request-for-Proposal Framework Supporting FDA IND Submission — Peivand Pirouzi, Happy Makvana, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS